TGA BioServices

TGA BioServices is a leading biotechnology research company dedicated to providing comprehensive laboratory services to the Pharmaceutical, Biotechnology, and Research communities. Inspected by the FDA, TGA BioServices supports both research and clinical studies, offering a complete package of customized testing systems that are utilized from preclinical stages through Phase IV studies, all in compliance with cGLP and cGMP requirements.

Located at 47 Hall Street, Medford, MA 02155, US, TGA BioServices specializes in the development and validation of immunoassay systems. These systems are designed for the detection of target molecules and antibody responses, as well as quantification in total compliance with QA and cGMP standards. TGA BioServices also excels in in vivo mouse studies, optimizing vaccine immunization schedules, dosing, and adjuvant screening. Their services extend to immunogenicity testing for the release and stability of bulk and finished clinical products, alongside complete antibody development programs.

TGA BioServices is committed to quality and innovation, offering additional services such as Guinea pig dermal sensitization testing for the identification of contact allergens. All programs are carefully supervised by an in-house Institutional Animal Care and Use Committee (IACUC), with the facility being USDA registered and AAALAC accredited. TGA BioServices continues to expand its capabilities, and more information will be available soon with the support of the company’s management. We invite the manager of TGA BioServices to create a customized and exclusive company showcase and product listing on our platform to further enhance your commercial development.